Companies / Anumana
Anumana develops ECG-AI algorithms that analyze standard 12-lead ECGs to detect cardiac conditions such as low ejection fraction and cardiac amyloidosis. It serves healthcare providers and health systems, offering a platform for integrating these algorithms into clinical workflows.
Summarized from its homepage on 15 Nov 2026.
Vendors of Anumana and the evidence for each
Google Tag ManagerWebsiteAnalyticsLikely
script: j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f15 Nov 2026anumana.aiFree
Google WorkspaceWebsiteProductivityLikely
WordPressWebsiteWebsites and CMSLikely
script: https://anumana.ai/wp-content/plugins/the-events-calendar/common/build/js/user15 Nov 2026anumana.aiFree
Google AnalyticsPrivacy policyAnalyticsLikely
No public list found
We did not find a public subprocessor list. The company may still publish one, or share it privately.
Vendor's own statement, retrieved from the source URL on the date shown. StrataDB does not verify the underlying claim. Data sources.
See Anumana's full stack
Every vendor with its source and date, and an alert when Anumana adds or drops one. The same lookup works for any company.
- Every vendor on every company page, with its public source
- 100 API calls a month, plus MCP and the Chrome extension
- Work email only. No card, no sales call